BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 18700844)

  • 1. Recent advances in refractory coeliac disease: a review.
    Ho-Yen C; Chang F; van der Walt J; Mitchell T; Ciclitira P
    Histopathology; 2009 Jun; 54(7):783-95. PubMed ID: 18700844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
    Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
    Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
    Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
    Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsule endoscopy in refractory celiac disease.
    Daum S; Wahnschaffe U; Glasenapp R; Borchert M; Ullrich R; Zeitz M; Faiss S
    Endoscopy; 2007 May; 39(5):455-8. PubMed ID: 17516353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enteropathy-associated T-cell lymphoma. Manifestation as diet-refractory coeliac disease and ulcerating jejunitis].
    Bächle T; Rühl U; Ott G; Walker S
    Dtsch Med Wochenschr; 2001 Dec; 126(51-52):1460-3. PubMed ID: 11753737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring nonresponsive patients who have celiac disease.
    Krauss N; Schuppan D
    Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of complicated celiac disease.
    Al-toma A; Verbeek WH; Mulder CJ
    Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory coeliac disease.
    Daum S; Cellier C; Mulder CJ
    Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
    Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
    Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased circulating iNKT cell numbers in refractory coeliac disease.
    Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
    Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory coeliac disease.
    Malamut G; Cellier C
    Curr Opin Oncol; 2013 Sep; 25(5):445-51. PubMed ID: 23942290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
    Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
    Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
    de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
    Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the management of refractory coeliac disease.
    Al-Toma A; Verbeek WH; Mulder CJ
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):57-63. PubMed ID: 17410290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune modulation by non-hodgkin lymphoma in a patient with two primary intestinal T-cell lymphomas and long-standing celiac disease.
    Mühr-Wilkenshoff F; Friedrich M; Foss HD; Hummel M; Zeitz M; Daum S
    Digestion; 2010; 81(4):231-4. PubMed ID: 20110707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease.
    Verbeek WH; von Blomberg BM; Scholten PE; Kuik DJ; Mulder CJ; Schreurs MW
    Am J Gastroenterol; 2008 Dec; 103(12):3152-8. PubMed ID: 19086962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma.
    Ashton-Key M; Diss TC; Pan L; Du MQ; Isaacson PG
    Am J Pathol; 1997 Aug; 151(2):493-8. PubMed ID: 9250161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients.
    Tjon JM; Kooy-Winkelaar YM; Tack GJ; Mommaas AM; Schreurs MW; Schilham MW; Mulder CJ; van Bergen J; Koning F
    J Immunol; 2011 Jun; 186(11):6304-12. PubMed ID: 21525383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Jejunal ulcerations - a diagnostic challenge in a patient with coeliac disease].
    Weber M; Schumann M; Felber J; Mireskandari M; Schmidt C; Stallmach A
    Z Gastroenterol; 2015 Nov; 53(11):1261-6. PubMed ID: 26562400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.
    Nasr I; Nasr I; Beyers C; Chang F; Donnelly S; Ciclitira PJ
    Nutrients; 2015 Dec; 7(12):9896-907. PubMed ID: 26633478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.